Last quarter (Q3 2025), BetterLife Pharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, BetterLife Pharma's net income was $601.65K. See BetterLife Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jan 24	Jan 23	Jan 22	Jan 21	Jan 20
Total Revenue	$ 305.44K	$ ―	$ ―	$ ―	$ ―	$ -40.03K
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ 305.44K	$ ―	$ ―	$ ―	$ ―	$ -40.03K
Operating Expense	$ 4.69M	$ 3.08M	$ 9.00M	$ 9.41M	$ 24.28M	$ 35.53M
Operating Income	$ -4.39M	$ -3.08M	$ -9.00M	$ -9.41M	$ -24.28M	$ -35.57M
Net Non Operating Interest Income Expense	$ -435.76K	$ -79.59K	$ -35.41K	$ -1.28M	$ -188.98K	$ -43.55K
Other Income Expense	$ -1.31M	$ -291.32K	$ 134.42K	$ -631.53K	$ -286.45K	$ -1.29M
Pretax Income	$ -3.55M	$ -2.90M	$ -9.37M	$ -10.29M	$ -36.34M	$ -42.59M
Tax Provision	$ ―	$ ―	$ ―	$ 166.67K	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -3.50M	$ -2.89M	$ -9.02M	$ -10.46M	$ -36.34M	$ -42.59M
Basic EPS	$ -0.04	$ -0.03	$ -0.10	$ -0.16	$ -1.34	$ -1.34
Diluted EPS	$ -0.04	$ -0.03	$ -0.10	$ -0.16	$ -1.34	$ -1.34
Basic Average Shares	$ 480.90M	$ 109.29M	$ 86.56M	$ 75.47M	$ 27.03M	$ 15.04M
Diluted Average Shares	$ 498.20M	$ 109.29M	$ 86.56M	$ 75.47M	$ 27.03M	$ 27.03M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 4.69M	$ 3.08M	$ 9.00M	$ 10.31M	$ 17.71M	$ 18.16M
Net Income From Continuing And Discontinued Operation	$ -3.50M	$ -2.89M	$ -9.02M	$ -10.46M	$ -36.34M	$ -42.59M
Normalized Income	$ -3.34M	$ -2.13M	$ -6.89M	$ -7.75M	$ 1.27M	$ -7.63M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -3.33M	$ -2.82M	$ -9.34M	$ -9.01M	$ -36.15M	$ -42.54M
EBITDA	$ -3.33M	$ -2.82M	$ -9.29M	$ -8.99M	$ -35.81M	$ -41.41M

Currency in USD

BetterLife Pharma Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing